6-K/A

AMENDMENT NO. 1

Company: Biodexa Pharmaceuticals Plc
Filed: July 19, 2024
Period of Report: July 19, 2024
Accession Number: 0001214659-24-012673

View Document ↗ View on SEC.gov ↗